. 2024; 21(2): 0-0 | |||
Investigation of PD-1 gene variants in patients with endometrial cancer, a case-control studyMohammad Javad Fattahi1, Mozhdeh Momtahan2, Maryam Poostkar1, Zahra Shiravani2, Zahra Shiravani3, Nasrollah Erfani1, Mohammad Reza Haghshenas1, Masoumeh Hashemi2, Abbas Ghaderi1, Ali Kashkooe11Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.2Gynecology Oncology Division, Department of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. 3Maternal-fetal Medicine Research Center, Department of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Objective: To evaluate the possible association of two single nucleotide polymorphisms (SNPs) including PD-1.3 (+7146G/A-rs11568821) and PD-1.5 (+7785C/T-rs2227981) with endometrial cancer (EC) susceptibility. In addition, the correlations between these SNPs and available clinicopathologic characteristics of EC patients were investigated. Mohammad Javad Fattahi, Mozhdeh Momtahan, Maryam Poostkar, Zahra Shiravani, Zahra Shiravani, Nasrollah Erfani, Mohammad Reza Haghshenas, Masoumeh Hashemi, Abbas Ghaderi, Ali Kashkooe. Investigation of PD-1 gene variants in patients with endometrial cancer, a case-control study. . 2024; 21(2): 0-0 Corresponding Author: Mohammad Javad Fattahi, Iran |
|